| RS2050032479 |
G6PC3
|
Health Risk |
Pathogenic |
Autosomal recessive severe congenital neutropenia due to G6PC3 deficiency, Autosomal recessive severe congenital neutropenia due to G6PC3 deficiency |
| RS2050043415 |
G6PC3
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Autosomal recessive severe congenital neutropenia due to G6PC3 deficiency |
| RS2050050950 |
FOXP1
|
Health Risk |
Pathogenic |
— |
| RS2050055854 |
G6PC3
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive severe congenital neutropenia due to G6PC3 deficiency, Autosomal recessive severe congenital neutropenia due to G6PC3 deficiency |
| RS2050059649 |
FOXP1
|
Health Risk |
Pathogenic |
— |
| RS2050068938 |
TTN
|
Health Risk |
Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2J, Dilated cardiomyopathy 1G |
| RS2050083156 |
TTN
|
Health Risk |
Likely pathogenic |
— |
| RS2050086519 |
TTN
|
Health Risk |
Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2J, Dilated cardiomyopathy 1G |
| RS2050086931 |
G6PC3
|
Health Risk |
Pathogenic |
— |
| RS2050087074 |
G6PC3
|
Health Risk |
Pathogenic |
— |
| RS2050087993 |
SCAF4
|
Health Risk |
Likely pathogenic |
— |
| RS2050096005 |
G6PC3
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive severe congenital neutropenia due to G6PC3 deficiency, Inborn genetic diseases |
| RS2050112328 |
ARHGEF9
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 8 |
| RS2050115619 |
ARHGEF9
|
Health Risk |
Conflicting classifications of pathogenicity |
Autism spectrum disorder, Developmental and epileptic encephalopathy |
| RS2050116026 |
TTN
|
Health Risk |
Pathogenic/Likely pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS2050117690 |
ARHGEF9
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2050120947 |
KIF1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary spastic paraplegia 30, Neuropathy |
| RS2050148457 |
SCAPER
|
Health Risk |
Likely pathogenic |
Intellectual developmental disorder and retinitis pigmentosa, IDDRP |
| RS2050180962 |
EPG5
|
Health Risk |
Pathogenic |
Vici syndrome, Vici syndrome |
| RS2050182643 |
SCAF4
|
Health Risk |
Pathogenic |
Fliedner-Zweier syndrome, Fliedner-Zweier syndrome |
| RS2050235998 |
GRIN2A
|
Health Risk |
Likely pathogenic |
Landau-Kleffner syndrome, Landau-Kleffner syndrome |
| RS2050240974 |
TTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1G, Dilated cardiomyopathy 1G |
| RS2050242587 |
GRIN2A
|
Health Risk |
Pathogenic |
Landau-Kleffner syndrome, Landau-Kleffner syndrome |
| RS2050247265 |
TTN
|
Health Risk |
Likely pathogenic |
Cardiomyopathy, Dilated cardiomyopathy 1G |
| RS2050261564 |
DIAPH3
|
Health Risk |
Pathogenic |
Autosomal dominant auditory neuropathy 1, Autosomal dominant auditory neuropathy 1 |
| RS2050278981 |
SCAF4
|
Health Risk |
Pathogenic |
— |
| RS2050305726 |
SCAF4
|
Health Risk |
Pathogenic |
— |
| RS2050313754 |
TTN
|
Health Risk |
Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2J, Dilated cardiomyopathy 1G |
| RS2050315855 |
TTN
|
Health Risk |
Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2J, Dilated cardiomyopathy 1G |
| RS2050437440 |
PYGL
|
Health Risk |
Likely pathogenic |
Glycogen storage disease, type VI |
| RS2050472602 |
EFTUD2
|
Health Risk |
Likely pathogenic |
— |
| RS2050473924 |
EFTUD2
|
Health Risk |
Pathogenic |
Mandibulofacial dysostosis-microcephaly syndrome, Mandibulofacial dysostosis-microcephaly syndrome |
| RS2050474390 |
EFTUD2
|
Health Risk |
Pathogenic/Likely pathogenic |
Mandibulofacial dysostosis-microcephaly syndrome, Mandibulofacial dysostosis-microcephaly syndrome |
| RS2050481336 |
EPG5
|
Health Risk |
Pathogenic |
Vici syndrome, Vici syndrome |
| RS2050490408 |
EFTUD2
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2050491591 |
PYGL
|
Health Risk |
Pathogenic |
— |
| RS2050493812 |
EFTUD2
|
Health Risk |
Pathogenic |
Esophageal atresia/tracheoesophageal fistula, Esophageal atresia/tracheoesophageal fistula |
| RS2050507811 |
EFTUD2
|
Health Risk |
Likely pathogenic |
Inborn genetic diseases, Mandibulofacial dysostosis-microcephaly syndrome |
| RS2050538888 |
SCAF4
|
Health Risk |
Pathogenic |
SCAF4-associated mental retardation, SCAF4-associated mental retardation |
| RS2050540072 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS2050549761 |
TTN
|
Health Risk |
Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2J, Dilated cardiomyopathy 1G |
| RS2050559188 |
TTN
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2J, Dilated cardiomyopathy 1G |
| RS2050571775 |
EFTUD2
|
Health Risk |
Conflicting classifications of pathogenicity |
Mandibulofacial dysostosis-microcephaly syndrome, Mandibulofacial dysostosis-microcephaly syndrome |
| RS2050589119 |
SCAF4
|
Health Risk |
Pathogenic |
Fliedner-Zweier syndrome, Fliedner-Zweier syndrome |
| RS2050602182 |
PYGL
|
Health Risk |
Pathogenic |
Glycogen storage disease, type VI |
| RS2050609487 |
EFTUD2
|
Health Risk |
Likely pathogenic |
Chromatinopathy, Chromatinopathy |
| RS2050617604 |
EPG5
|
Health Risk |
Pathogenic |
Vici syndrome, Vici syndrome |
| RS2050642774 |
PPARG
|
Health Risk |
Pathogenic |
PPARG-related familial partial lipodystrophy, PPARG-related familial partial lipodystrophy |
| RS2050647141 |
PPARG
|
Health Risk |
Likely pathogenic |
PPARG-related familial partial lipodystrophy, PPARG-related familial partial lipodystrophy |
| RS2050647473 |
PPARG
|
Health Risk |
Likely pathogenic |
PPARG-related familial partial lipodystrophy, PPARG-related familial partial lipodystrophy |
| RS2050651799 |
PPARG
|
Health Risk |
Likely pathogenic |
— |
| RS2050657361 |
TTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS2050680680 |
EFTUD2
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2050689146 |
KIF1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary spastic paraplegia 30, Neuropathy |
| RS2050697632 |
EFTUD2
|
Health Risk |
Pathogenic |
Mandibulofacial dysostosis-microcephaly syndrome, Mandibulofacial dysostosis-microcephaly syndrome |
| RS2050707804 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS2050721026 |
EFTUD2
|
Health Risk |
Pathogenic |
— |
| RS2050729007 |
PYGL
|
Health Risk |
Likely pathogenic |
— |
| RS2050731690 |
PYGL
|
Health Risk |
Pathogenic |
Glycogen storage disease, type VI |
| RS2050744878 |
DAG1
|
Health Risk |
Pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2P, Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies) |
| RS2050749062 |
KIF1A
|
Health Risk |
Likely pathogenic |
Hereditary spastic paraplegia 30, Hereditary spastic paraplegia 30 |
| RS2050761292 |
KIF1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Neuropathy, hereditary sensory |
| RS2050786898 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Early-onset myopathy with fatal cardiomyopathy, Dilated cardiomyopathy 1G |
| RS2050794694 |
PEX12
|
Health Risk |
Pathogenic |
Peroxisome biogenesis disorder 3A (Zellweger), Peroxisome biogenesis disorder 3A (Zellweger) |
| RS2050845376 |
TTN
|
Health Risk |
Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2J, Dilated cardiomyopathy 1G |
| RS2050848238 |
FECH
|
Health Risk |
Pathogenic |
See cases, See cases |
| RS2050849085 |
FECH
|
Health Risk |
Conflicting classifications of pathogenicity |
FECH-related disorder, Protoporphyria |
| RS2050854171 |
TTN
|
Health Risk |
Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2J, Dilated cardiomyopathy 1G |
| RS2050856829 |
BRCA1
|
Health Risk |
Likely pathogenic |
Hereditary breast ovarian cancer syndrome, Hereditary breast ovarian cancer syndrome |
| RS2050859456 |
BRCA1
|
Health Risk |
Likely pathogenic |
Hereditary breast ovarian cancer syndrome, Hereditary breast ovarian cancer syndrome |
| RS2050860445 |
TTN
|
Health Risk |
Likely pathogenic |
Tibial muscular dystrophy, Tibial muscular dystrophy |
| RS2050860958 |
BRCA1
|
Health Risk |
Likely pathogenic |
Breast-ovarian cancer, familial |
| RS2050861886 |
BRCA1
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary breast ovarian cancer syndrome, Breast-ovarian cancer |
| RS2050862880 |
BRCA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary breast ovarian cancer syndrome, Breast-ovarian cancer |
| RS2050864747 |
BRCA1
|
Health Risk |
Likely pathogenic |
Breast-ovarian cancer, familial |
| RS2050885130 |
BRCA1
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS2050888713 |
TTN
|
Health Risk |
Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2J, Dilated cardiomyopathy 1G |
| RS2050891633 |
BRCA1
|
Health Risk |
Likely pathogenic |
Breast-ovarian cancer, familial |
| RS2050902019 |
EPG5
|
Health Risk |
Pathogenic |
Vici syndrome, Vici syndrome |
| RS2050933471 |
CNP
|
Health Risk |
Pathogenic |
Leukodystrophy, hypomyelinating |
| RS2050937885 |
EPG5
|
Health Risk |
Pathogenic |
Vici syndrome, Vici syndrome |
| RS2050942396 |
EFTUD2
|
Health Risk |
Likely pathogenic |
— |
| RS2050976068 |
BRCA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Breast-ovarian cancer, familial |
| RS2050988927 |
BRCA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Breast-ovarian cancer, familial |
| RS2050991229 |
BRCA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Breast-ovarian cancer, familial |
| RS2050992362 |
BRCA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Breast-ovarian cancer, familial |
| RS2050994882 |
BRCA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Breast-ovarian cancer, familial |
| RS2051003587 |
TTN
|
Health Risk |
Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2J, Dilated cardiomyopathy 1G |
| RS2051026773 |
CNP
|
Health Risk |
Pathogenic |
Myopia 2, autosomal dominant |
| RS2051032338 |
EFTUD2
|
Health Risk |
Pathogenic |
Mandibulofacial dysostosis-microcephaly syndrome, Mandibulofacial dysostosis-microcephaly syndrome |
| RS2051069083 |
BRCA1
|
Health Risk |
Likely pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2051069733 |
BRCA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Breast-ovarian cancer, familial |
| RS2051071309 |
BRCA1
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS2051071982 |
BRCA1
|
Health Risk |
Pathogenic |
— |
| RS2051072173 |
BRCA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Breast-ovarian cancer, familial |
| RS2051074344 |
BRCA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Breast-ovarian cancer, familial |
| RS2051078701 |
BRCA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Breast-ovarian cancer, familial |
| RS2051085308 |
BRCA1
|
Health Risk |
Likely pathogenic |
Breast-ovarian cancer, familial |
| RS2051091746 |
BRCA1
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary breast ovarian cancer syndrome |
| RS2051091768 |
KIF1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary spastic paraplegia, Hereditary spastic paraplegia 30 |